logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9078885 B1

PDFFull Text
Expired
Date of Patent:
Jul. 14, 2015

Filed:

Apr. 07, 2014

Respiratory disease treatment

Applicant:

Pulmagen Therapeutics (Inflammation) Limited, Buckinghamshire, GB;

Inventors:

Harry Finch, Buckinghamshire, GB;

Craig Fox, Buckinghamshire, GB;

Mohammed Sajad, Essex, GB;

Monique Bondil Van Niel, Essex, SE;

Andrew Forrest, Essex, GB;

Assignee:

Pulmagen Therapeutics (Inflammation) Limited, Buckinghamshire, GB;

Attorney:

Morgan, Lewis & Bockius LLP

Primary Examiner:

Wu-Cheng Winston Shen

Assistant Examiner:

Jean Cornet

Int. Cl.
CPC ...
A01N 43/00 (2006.01); A61K 31/33 (2006.01); A61K 31/4439 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 31/56 (2006.01); A61K 31/573 (2006.01); A61K 31/58 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4439 (2013.01); A61K 9/0075 (2013.01); A61K 31/56 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61K 45/06 (2013.01);
Abstract

A pharmaceutical composition adapted for pulmonary administration by inhalation is described, wherein the composition comprises a glitazone and one or more pharmaceutically acceptable carriers and/or excipients, wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer, and wherein the glitazone is pioglitazone or rosiglitazone or a pharmaceutically acceptable salt thereof, and wherein the glitazone is in the form of microparticles.

Find Patent Forward Citations

Finch, Harry. (2015). Respiratory disease treatment (U.S. Patent No. 9078885). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9078885

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…